Steven Kornfeld

California, USA

Healthcare, Agriculture Tech, All

Partner, Castle Peak Partners, 20 years Portfolio Manager at Franklin Templeton

Steven Kornfeld - Steven Kornfeld is a seasoned investment professional and strategic advisor with three decades of experience in strategy, capital allocation, capital markets, governance and risk management.
Steven currently serves as a partner at Castle Peak Partners, an investment firm which collaborates with entrepreneurs of early-stage companies. Steven serves on the Board of Directors of JayBirds Chicken, a fast-casual restaurant chain. Steven serves as a Board Observer of Lark Health, an AI powered platform for managing chronic diseases. Steven serves as an independent director of Forte Biosciences (NASDAQ: FBRX), where he chairs the Compensation Committee and serves on the Audit Committee.
Until February 2020, Steven served as a Vice President, Portfolio Manager, Research Analyst and Sector Team Leader for Franklin Templeton Investments, where he worked since 2001. Steven led the US equity health care investment research team, allocating up to $10 billion in investments in the biopharmaceutical and health care services industries. In this role, he regularly spoke with C-Suite executives to evaluate strategy, culture and business trends to support capital allocation decisions. Under his direction, Franklin was a frequent top-ten shareholder in several global healthcare companies including Abbvie, Allergan, AstraZeneca, CVS, Lilly, Merck, Mettler-Toledo, and Pfizer, often committing up to $1 billion in capital to individual companies.